Nektar Therapeutics's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
Nektar Therapeutics last closed at $41.17 (+0.91%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -8.6×. Its overall grade ranks 385 of 738 stocks in Healthcare.
About this company
Nektar Therapeutics last closed at $41.17 (+0.91%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 385/738
Valuation grade A-
Related stocks
- Bristol-Myers SquibbCustomer
Nektar의 면역항암제 후보 NKTR-214(아네토키맙 계열) 공동개발 이력과 파트너 관계
- Eli LillyCustomer
Nektar와 과거 면역질환·신약 후보 공동개발 협력 이력
- AmgenCustomer
Nektar의 약물전달/제형 플랫폼 및 공동개발 협력 이력
About Nektar Therapeutics
- What technical signals does Nektar Therapeutics (NKTR) have?
- Nektar Therapeutics current technical signals: no active technical signal.
- Is Nektar Therapeutics a cup-and-handle pattern?
- No. Nektar Therapeutics has no valid Cup signal right now.
- What published figures are available for Nektar Therapeutics?
- Market cap: $837.46M. Trailing 12 months PER: -8.6×. Latest quarter PBR: 1.49×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Nektar Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.